WVE News and Press, Wave Life Sciences Ltd. From 03/02/22

ABUS, ARGX, ASPS, ATRS, BBY, BF.B, BIG, BILI, BJ, BURL, CAN, CNCE, CNQ, CNSL, CPG, CRH, OTCQX:DLAKF, EYPT, GLYC, GOGO, GRAB, HTOO, KR, MBT, MCS, MEI, OTCPK:MKGAF, MTLS, OXSQ, REE, REV, SBSW, OTCPK:SNCAF, SOHO, SRLP, STXS, SUP, TD, TGLS, TTC, TTSH, TWI, TZOO, UONE, UTZ, WB, WHF, WVE For Seekin...

CAMBRIDGE, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and ...

CAMBRIDGE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and ...

Wave paper on PN chemistry for silencing in the CNS, and the implications for oligonucleotides more broadly, designated as a Breakthrough Article by Nucleic Acids Research Publications highlight the profound impact of PN chemistry on potency, distribution, and durability of effect...

ADDF and AFTD Partner to Support Wave Life Sciences' FTD and ALS Clinical Program PR Newswire NEW YORK , Jan. 25, 2022 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) announced today that...

Vintage Wine Estates marks eight years and one million meals donated through its Angels Share campaign to fight food insecurity PR Newswire SANTA ROSA, Calif. , Dec. 23, 2021 /PRNewswire/ -- Vintage Wine Estates, Inc. (NASDAQ: VWE) (TSX: VWE.U) (TSX: VWE.WT.U) ("...

The following slide deck was published by Wave Life Sciences Ltd. in conjunction with their 2021 Q3 earnings call. For further details see: Wave Life Sciences Ltd. 2021 Q3 - Results - Earnings Call Presentation

Wave Life Sciences Ltd. (WVE) Q3 2021 Earnings Conference Call Nov 10, 2021 08:30 AM ET Company Participants Kate Rausch - Head of Investor Relations Paul Bolno - President & Chief Executive Officer Chandra Vargeese - Chief Technology Officer Mike Panzara - Chief Medical Officer, Head of ...

Wave Life Sciences (NASDAQ:WVE): Q3 GAAP EPS of -$0.12 beats by $0.52. Revenue of $36.42M (+955.7% Y/Y) beats by $26.06M. Press Release For further details see: Wave Life Sciences EPS beats by $0.52, beats on revenue

Strengthened balance sheet with approximately $52 million; focusing additional investment in RNA editing programs led by hepatic editing Optimized AIMers for AATD program demonstrate potent, highly specific RNA editing and restoration of functional AAT protein substantially abov...